Medindia

X

Lupin Gets USFDA Approval for Meloxicam

by Medindia Content Team on  July 21, 2006 at 11:39 AM Drug News   - G J E 4
Lupin Gets USFDA Approval for Meloxicam
Lupin Ltd today said it has got the approval of US Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Meloxicam tablets used in the treatment of osteoarthritis and rheumatoid arthritis.
Advertisement

The approval is for Meloxicam tablets of strengths of 7.5 mg and 15 mg , the company informed the Bombay Stock Exchange.

Advertisement
"The approval of our Meloxicam ANDA further reinforces Lupin's ability on submitting high quality dossiers and gaining approval in time. Our thorough execution has enabled us to launch the product immediately," Lupin Managing Director Kamal K Sharma said.

Meloxicam is a generic equivalent of Boehringer Ingelheim's non-steroidal anti-inflammatory drug (NSAID), Mobic. Its sales in the US were approximately 1.1 billion dollars for the 12-month period ended December 2005 according to IMS Health, it added.

This is the company's 14th ANDA approval from US FDA, it said.

Source:PTI News
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All